Literature DB >> 11840509

Association between a polymorphism in the pseudoautosomal X-linked gene SYBL1 and bipolar affective disorder.

Daniel J Müller1, Thomas G Schulze, Esther Jahnes, Sven Cichon, Harald Krauss, Kristina Kesper, Tilo Held, Wolfgang Maier, Peter Propping, Markus M Nöthen, Marcella Rietschel.   

Abstract

In the past decade, several chromosomal regions have been analyzed for linkage with bipolar affective disorder (BPAD). There have been conflicting results regarding the involvement of X-chromosomal regions in harboring susceptibility genes for BPAD. Recently, a new candidate gene (SYBL1) for BPAD has been described on Xq28. SYBL1, which maps to the Xq pseudoautosomal region (PAR), encodes a member of the synaptobrevin family of proteins involved in synaptic vesicle docking, exocytosis, and membrane transport. A subsequent case-control association study, including 110 US-American patients with BPAD and 119 unrelated controls, investigated a potential etiological role of a novel polymorphism (G-->C transversion) in a regulatory region of the SYBL1 gene. In this analysis, the C allele showed a statistical trend to be more frequent in males with BPAD than in respective controls (P=0.06). This finding prompted us to verify whether a similar effect was also present in a larger German sample of 164 unrelated patients with BPAD (148 patients with BP I disorder, 16 patients with BP II disorder) and 267 controls. We observed a significantly increased frequency of genotypes homozygous for the C allele in females with BPAD in comparison with controls (P=0.017). Thus, our data strengthen the role of the SYBL1 gene as a candidate gene for BPAD. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11840509     DOI: 10.1002/ajmg.10115

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  The Human Pseudoautosomal Region (PAR): Origin, Function and Future.

Authors:  A Helena Mangs; Brian J Morris
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

2.  Membrane Trafficking in Neuronal Development: Ins and Outs of Neural Connectivity.

Authors:  Cortney Chelise Winkle; Stephanie L Gupton
Journal:  Int Rev Cell Mol Biol       Date:  2016-01-06       Impact factor: 6.813

Review 3.  Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders.

Authors:  Rafael T de Sousa; Alexandre A Loch; André F Carvalho; André R Brunoni; Marie Reine Haddad; Ioline D Henter; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Neuropsychopharmacology       Date:  2016-08-11       Impact factor: 7.853

Review 4.  Endocytosis and signaling: cell logistics shape the eukaryotic cell plan.

Authors:  Sara Sigismund; Stefano Confalonieri; Andrea Ciliberto; Simona Polo; Giorgio Scita; Pier Paolo Di Fiore
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

Review 5.  Mechanisms underlying neurocognitive dysfunctions in recurrent major depression.

Authors:  Piotr Gałecki; Monika Talarowska; George Anderson; Michael Berk; Michael Maes
Journal:  Med Sci Monit       Date:  2015-05-27

Review 6.  The XY gene hypothesis of psychosis: origins and current status.

Authors:  Timothy J Crow
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-10-03       Impact factor: 3.568

Review 7.  Sex chromosome abnormalities and psychiatric diseases.

Authors:  Xinzhu Zhang; Jian Yang; Yuhong Li; Xin Ma; Rena Li
Journal:  Oncotarget       Date:  2017-01-17

8.  Inherited duplication of the pseudoautosomal region Xq28 in a subject with Gilles de la Tourette syndrome and intellectual disability: a case report.

Authors:  Stefania Maccarini; Annamaria Cipani; Valeria Bertini; Jelena Skripac; Alessandro Salvi; Giuseppe Borsani; Eleonora Marchina
Journal:  Mol Cytogenet       Date:  2020-06-22       Impact factor: 2.009

9.  ASMT gene expression correlates with cognitive impairment in patients with recurrent depressive disorder.

Authors:  Monika Talarowska; Janusz Szemraj; Marlena Zajączkowska; Piotr Gałecki
Journal:  Med Sci Monit       Date:  2014-06-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.